Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S, Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S, Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G, Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R, Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F, D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G, Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group.

J Autoimmun. 2020 Jan 8:102397. doi: 10.1016/j.jaut.2019.102397. [Epub ahead of print]

PMID:
31926833
2.

Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress.

Emmi G, Mannucci A, Argento FR, Silvestri E, Vaglio A, Bettiol A, Fanelli A, Stefani L, Taddei N, Prisco D, Fiorillo C, Becatti M.

Front Immunol. 2019 Dec 13;10:2877. doi: 10.3389/fimmu.2019.02877. eCollection 2019.

3.

Treating the Different Phenotypes of Behçet's Syndrome.

Bettiol A, Hatemi G, Vannozzi L, Barilaro A, Prisco D, Emmi G.

Front Immunol. 2019 Dec 6;10:2830. doi: 10.3389/fimmu.2019.02830. eCollection 2019. Review.

4.

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors.

Fabiani C, Vitale A, Emmi G, Sgheri A, Lopalco G, Sota J, Guerriero S, Iannone F, Frediani B, Vannozzi L, Bianco MT, Giovannini V, Tosi GM, Cantarini L.

Front Pharmacol. 2019 Dec 9;10:1468. doi: 10.3389/fphar.2019.01468. eCollection 2019.

5.

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.

J Clin Med. 2019 Nov 18;8(11). pii: E2013. doi: 10.3390/jcm8112013.

6.

Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients.

Urban ML, Maritati F, Palmisano A, Fenaroli P, Peyronel F, Trivioli G, Ferretti S, De Biase C, Grayson PC, Pegoraro F, Prisco D, Romagnani P, Emmi G, Vaglio A.

Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-216258. doi: 10.1136/annrheumdis-2019-216258. [Epub ahead of print] No abstract available.

PMID:
31744824
7.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.

Lyons PA, Peters JE, Alberici F, Liley J, Coulson RMR, Astle W, Baldini C, Bonatti F, Cid MC, Elding H, Emmi G, Epplen J, Guillevin L, Jayne DRW, Jiang T, Gunnarsson I, Lamprecht P, Leslie S, Little MA, Martorana D, Moosig F, Neumann T, Ohlsson S, Quickert S, Ramirez GA, Rewerska B, Schett G, Sinico RA, Szczeklik W, Tesar V, Vukcevic D; European Vasculitis Genetics Consortium, Terrier B, Watts RA, Vaglio A, Holle JU, Wallace C, Smith KGC.

Nat Commun. 2019 Nov 12;10(1):5120. doi: 10.1038/s41467-019-12515-9.

8.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
9.

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study.

Prete M, Favoino E, Giacomelli R, Afeltra A, Cantatore FP, Bruno C, Corrado A, Emmi L, Emmi G, Grembiale RD, Navarini L, Marcoccia A, Liakouli V, Riccardi A, Valentini G, Perosa F; GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale).

Clin Exp Med. 2019 Nov 2. doi: 10.1007/s10238-019-00589-0. [Epub ahead of print]

PMID:
31679095
10.

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y.

Eur J Prev Cardiol. 2019 Oct 15:2047487319879534. doi: 10.1177/2047487319879534. [Epub ahead of print]

PMID:
31610707
11.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

12.

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE, Navarini L, Destro Castaniti GM, Maruotti N, Di Scala G, Picciariello L, Caso F, Bongiovanni S, Grembiale RD, Atzeni F, Scarpa R, Perosa F, Emmi G, Cantatore FP, Guggino G, Afeltra A, Ciccia F, Giacomelli R.

Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.

13.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
14.

New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group.

Marvisi C, Sinico RA, Salvarani C, Jayne D, Prisco D, Terrier B, Emmi G, Vaglio A; European EGPA Study Group.

Intern Emerg Med. 2019 Nov;14(8):1193-1197. doi: 10.1007/s11739-019-02166-5. Epub 2019 Aug 6.

PMID:
31388893
15.

Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments.

Emmi G, Prisco D.

Intern Emerg Med. 2019 Aug;14(5):639-643. doi: 10.1007/s11739-019-02154-9. Epub 2019 Jul 17. No abstract available.

PMID:
31317313
16.

Intravenous immunoglobulin therapy: a snapshot for the internist.

Vitiello G, Emmi G, Silvestri E, Di Scala G, Palterer B, Parronchi P.

Intern Emerg Med. 2019 Oct;14(7):1041-1049. doi: 10.1007/s11739-019-02150-z. Epub 2019 Jul 15. Review.

PMID:
31309519
17.

Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils.

Emmi G, Becatti M, Bettiol A, Hatemi G, Prisco D, Fiorillo C.

Front Immunol. 2019 May 14;10:1085. doi: 10.3389/fimmu.2019.01085. eCollection 2019. Review.

18.

Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients.

Cassia MA, Alberici F, Jones RB, Smith RM, Casazza G, Urban ML, Emmi G, Moroni G, Sinico RA, Messa P, Hall F, Vaglio A, Gallieni M, Jayne DR.

Arthritis Rheumatol. 2019 Oct;71(10):1670-1680. doi: 10.1002/art.40932. Epub 2019 Aug 30.

19.

Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.

Bruschi M, Bonanni A, Petretto A, Vaglio A, Pratesi F, Santucci L, Migliorini P, Bertelli R, Galetti M, Belletti S, Cavagna L, Moroni G, Franceschini F, Fredi M, Pazzola G, Allegri L, Sinico RA, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Ramoino P, Bianchini P, Puppo F, Pupo F, Negrini S, Mattana F, Emmi G, Garibotto G, Santoro D, Scolari F, Ravelli A, Tincani A, Cravedi P, Volpi S, Candiano G, Ghiggeri GM.

J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232. [Epub ahead of print]

PMID:
31092713
20.

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.

PMID:
31025925
21.

Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients.

Maritati F, Rocco R, Accorsi Buttini E, Marvisi C, Nicastro M, Urban ML, Fenaroli P, Peyronel F, Benigno GD, Palumbo AA, Corradi D, Emmi G, Pipitone N, Palmisano A, Vaglio A.

Front Immunol. 2019 Apr 4;10:693. doi: 10.3389/fimmu.2019.00693. eCollection 2019.

22.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

23.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

24.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

25.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

26.

Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.

Benagiano M, Borghi MO, Romagnoli J, Mahler M, Bella CD, Grassi A, Capitani N, Emmi G, Troilo A, Silvestri E, Emmi L, Alnwaisri H, Bitetti J, Tapinassi S, Prisco D, Baldari CT, Meroni PL, D'Elios MM.

Haematologica. 2019 Dec;104(12):2519-2527. doi: 10.3324/haematol.2018.209536. Epub 2019 Mar 14.

27.

The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic review.

Bettiol A, Silvestri E, Di Scala G, Amedei A, Becatti M, Fiorillo C, Lopalco G, Salvarani C, Cantarini L, Soriano A, Emmi G.

Rheumatol Int. 2019 Jun;39(6):971-990. doi: 10.1007/s00296-019-04259-y. Epub 2019 Feb 25.

PMID:
30799530
28.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

29.

Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment.

Emmi G, Bettiol A, Palterer B, Silvestri E, Vitiello G, Parronchi P, Prisco D.

Autoimmun Rev. 2019 Mar;18(3):312-314. doi: 10.1016/j.autrev.2018.11.002. Epub 2019 Jan 11. No abstract available.

PMID:
30639638
30.

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.

González-Serna D, Carmona EG, Ortego-Centeno N, Simeón CP, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F; European GCA Consortium; European Scleroderma Group, Witte T, Neumann T, Holle J, Beretta L, Boiardi L, Emmi G, Cimmino MA, Vaglio A, Herrick AL, Denton CP, Salvarani C, Cid MC, Morgan AW, Fonseca C, González-Gay MA, Martín J, Márquez A.

PLoS One. 2018 Dec 26;13(12):e0209343. doi: 10.1371/journal.pone.0209343. eCollection 2018.

31.

Reply.

Emmi G, Bettiol A.

Arthritis Rheumatol. 2019 Apr;71(4):657-658. doi: 10.1002/art.40794. Epub 2019 Mar 2. No abstract available.

PMID:
30537215
32.

Vascular Behçet's syndrome: an update.

Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D.

Intern Emerg Med. 2019 Aug;14(5):645-652. doi: 10.1007/s11739-018-1991-y. Epub 2018 Nov 29. Review.

PMID:
30499073
33.

Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects.

Becatti M, Emmi G, Bettiol A, Silvestri E, Di Scala G, Taddei N, Prisco D, Fiorillo C.

Clin Exp Immunol. 2019 Mar;195(3):322-333. doi: 10.1111/cei.13243. Epub 2018 Dec 18. Review.

PMID:
30472725
34.

Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study.

Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D.

Int J Cardiol. 2019 Jan 1;274:1-6. doi: 10.1016/j.ijcard.2018.06.010. Epub 2018 Jun 5.

PMID:
30454720
35.

Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.

Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O'Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M; American and European Network of Antisynthetase Syndrome Collaborative Group.

J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15.

PMID:
30442823
36.

Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.

Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.

Immunol Lett. 2018 Sep;201:38-44. doi: 10.1016/j.imlet.2018.10.013. Epub 2018 Oct 29.

PMID:
30385329
37.

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.

Lopalco G, Venerito V, Cantarini L, Emmi G, Prisco D, Iannone F.

Intern Emerg Med. 2019 Aug;14(5):719-722. doi: 10.1007/s11739-018-1970-3. Epub 2018 Oct 25. No abstract available.

PMID:
30361849
38.

Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial.

Rossi GM, Mannoni A, Di Scala G, Silvestri E, Cojan RD, Vannozzi L, Bettiol A, Vaglio A, Emmi G.

Autoimmun Rev. 2018 Dec;17(12):1265-1267. doi: 10.1016/j.autrev.2018.07.004. Epub 2018 Oct 12. No abstract available.

PMID:
30316991
39.

Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis.

Alberici F, Bonatti F, Maritati F, Urban ML, Moroni G, Emmi G, Adorni A, Reina M, Vaglio A, Martorana D.

Clin Exp Rheumatol. 2018 Mar-Apr;37(2):222-226. Epub 2018 Sep 17.

40.

The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies.

Di Minno MND, Scalera A, Tufano A, Ambrosino P, Bettiol A, Silvestri E, Emmi G, Prisco D.

Atherosclerosis. 2018 Nov;278:60-65. doi: 10.1016/j.atherosclerosis.2018.09.010. Epub 2018 Sep 14.

PMID:
30253290
41.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Di Scala G, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):267. doi: 10.1007/s10067-018-4302-0.

PMID:
30242638
42.

Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies.

Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D.

Data Brief. 2018 Jun 27;19:1799-1803. doi: 10.1016/j.dib.2018.06.083. eCollection 2018 Aug.

43.

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study.

Di Scala G, Bettiol A, Cojan RD, Finocchi M, Silvestri E, Emmi G.

J Autoimmun. 2019 Feb;97:108-113. doi: 10.1016/j.jaut.2018.09.002. Epub 2018 Sep 11.

PMID:
30213443
44.

Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role.

Prisco D, Silvestri E, Di Scala G, Emmi G.

Rheumatology (Oxford). 2019 Apr 1;58(4):563-564. doi: 10.1093/rheumatology/key279. No abstract available.

PMID:
30202974
45.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]

PMID:
30148652
46.

Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience.

Becatti M, Urban ML, Taurisano G, Mannucci A, Barygina V, Pescitelli L, Prignano F, Silvestri E, Taddei N, Lotti T, Fiorillo C, Emmi G.

Dermatol Ther. 2018 Sep;31(5):e12675. doi: 10.1111/dth.12675. Epub 2018 Aug 22. No abstract available.

PMID:
30133998
47.

Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.

Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L.

Isr Med Assoc J. 2018 Jul;20(7):438-441.

48.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Gentileschi S, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Feb;38(2):407-415. doi: 10.1007/s10067-018-4228-6. Epub 2018 Aug 11.

PMID:
30099655
49.

A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis.

Martorana D, Márquez A, Carmona FD, Bonatti F, Adorni A, Urban ML, Maritati F, Accorsi Buttini E, Marvisi C, Palmisano A, Rossi GM, Trivioli G, Fenaroli P, Manenti L, Nicastro M, Incerti M, Gianfreda D, Bani S, Ferretti S, Corradi D, Alberici F, Emmi G, Di Scala G, Moroni G, Percesepe A, Scheel PJ Jr, Vermeer E, van Bommel EF, Martín J, Vaglio A.

J Allergy Clin Immunol. 2018 Nov;142(5):1662-1665. doi: 10.1016/j.jaci.2018.06.045. Epub 2018 Aug 4. No abstract available.

PMID:
30081155
50.

Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term.

Brucato A, Imazio M, Cremer PC, Adler Y, Maisch B, Lazaros G, Gattorno M, Caforio ALP, Marcolongo R, Emmi G, Martini A, Klein AL.

Intern Emerg Med. 2018 Sep;13(6):839-844. doi: 10.1007/s11739-018-1907-x. Epub 2018 Jul 18. Review.

PMID:
30022399

Supplemental Content

Support Center